Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

6.9%

18 terminated/withdrawn out of 261 trials

Success Rate

90.4%

+3.9% vs industry average

Late-Stage Pipeline

11%

30 trials in Phase 3/4

Results Transparency

14%

24 of 169 completed trials have results

Key Signals

23 recruiting24 with results13 terminated5 withdrawn

Enrollment Performance

Analytics

N/A

122(57.8%)

Phase 1

33(15.6%)

Phase 2

25(11.8%)

Phase 3

19(9.0%)

Phase 4

11(5.2%)

Early Phase 1

1(0.5%)

211Total

N/A(122)

Phase 1(33)

Phase 2(25)

Phase 3(19)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (261)

Showing 20 of 261 trials

NCT07334912Phase 2Recruiting

AEF0217 in Participants With Down Syndrome

Role: collaborator

NCT05461729Recruiting

TIMELY-PrädiktoR Prospective Study

Role: collaborator

NCT06368310Not ApplicableRecruiting

FIH Clinical Investigation of Graphene Electrodes for Brain Mapping

Role: collaborator

NCT07129408Completed

Epidemiological Study on the Prevalence of Mental Disorders in Slovakia

Role: collaborator

NCT02655315Phase 2Completed

Conservative Iron Chelation as a Disease-modifying Strategy in Parkinson's Disease

Role: collaborator

NCT05701228Active Not Recruiting

Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation

Role: collaborator

NCT06816147Not ApplicableRecruiting

HealthyW8_60+ Pilot

Role: collaborator

NCT06731244Not ApplicableRecruiting

Shared Decision-making Process for Unprovoked vEnous THromboEmbolism Management. (ETHER )

Role: collaborator

NCT03517865Active Not Recruiting

International Primary Ciliary Dyskinesia Cohort

Role: collaborator

NCT06605079Not ApplicableRecruiting

Enhancing Palliative Care in ICU

Role: collaborator

NCT02490501Phase 1Completed

Safety and Efficacy of SC0806 (Fibroblast Growth Factor 1 and a Device) in Traumatic Spinal Cord Injury Subjects

Role: collaborator

NCT05223413Not ApplicableRecruiting

REmote iSchemic condItioning in Lymphoma PatIents REceiving ANthraCyclinEs

Role: collaborator

NCT06179602Recruiting

Prospective Cohort Study on Thermal Ablation of Malignant Liver Tumors

Role: collaborator

NCT05965427Completed

Morbidity, Mortality And Risk Factors of Mpox in HIV Negative High Risk Sexual Health Clinic Attenders and People Living With HIV

Role: collaborator

NCT05994690Phase 3Recruiting

CHIP-AML22/Master: An Open Label Complex Clinical Trial in Newly Diagnosed Pediatric de Novo AML Patients

Role: collaborator

NCT03571373Recruiting

PIBD-SETQuality: the Inception Cohort and Safety Registry

Role: collaborator

NCT03750201Not ApplicableCompleted

A Study to Assess an Automated Laser Device for Direct Selective Laser Trabeculoplasty

Role: collaborator

NCT04832607Phase 3Recruiting

Multivirus-specific T-cell Transfer Post SCT vs AdV, CMV and EBV Infections

Role: collaborator

NCT04844775Phase 1Completed

A Prophylactic HIV Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Clade C DREP Alone and in Combination With a Clade C ENV Protein in Healthy HIV-uninfected Adults

Role: collaborator

NCT04297813Phase 3Completed

Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting

Role: collaborator